Dr. Chase on Toxicities of Treatments for Ovarian Cancer

Video

Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologist oncologist with Arizona Oncology, discusses the toxicity profiles and managing side effects of treatments for patients with recurrent ovarian cancer.

Dana M. Chase, MD, FACOG, an associate professor at Creighton University, University of Arizona College of Medicine, and gynecologist oncologist with Arizona Oncology, discusses the toxicity profiles and managing side effects of treatments for patients with recurrent ovarian cancer.

The biggest side effect of paclitaxel, one of the most commonly used drugs for ovarian cancer, is hair loss, explains Chase. When combined with carboplatin, paclitaxel can also cause fatigue and neuropathy. Nausea and vomiting are also common side effects with various other chemotherapy regimens.

Bevacizumab (Avastin) is a very well-tolerated drug and most of the toxicities are manageable. There are medications to manage the hypertension allowing bevacizumab to be taken long term, states Chase.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD